STRATEC Biomedical AG 

07.05.2014 19:28

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Correction of the release dated April 30, 2014

1. Herdor GmbH & Co. KG, Unterschleißheim, Germany, notified us pursuant to sec 21 para 1 of the German Securities Trading Act (WpHG) that its share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 10, 15, 20 and 25% on April 27, 2014 and amounted to 25.40% on this date (2,990,000 voting rights). Of these, 15.72% (1,850,000 voting rights) were attributable to it pursuant to sec. 22 para 2 WpHG via Tanja van Dinter, Bettina Siegle and Ralf Leistner, which all hold at least 3% of the voting rights.

2. Herdor Beteiligungs GmbH, Unterschleißheim, Germany, notified us pursuant to sec. 21 para 1 of the German Securities Trading Act (WpHG) that its share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, exceeded the thresholds of 10, 15, 20 and 25% on April 27, 2014 and amounted to 25.40% on this date (2,990,000 voting rights). Of these, 25.40% (2.990,000 voting rights) were attributable to it pursuant both to sec. 22 para 1 sentence 1 no. 1 WpHG and to sec. 22 para 2 WpHG via Herdor GmbH & Co. KG, Tanja van Dinter, Bettina Siegle and Ralf Leistner, which all hold at least 3% of the voting rights.



07.05.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---